Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29358100

NC(=O)c1cccnc1-c1ccc(Cc2cccc(Cl)c2)cn1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
BRS3 P32247 1/20 0.38
GPR6 P46095 2/20 0.38
AKT1 P31749 1/20 0.37
GPR52 Q9Y2T5 7/20 0.36
RORB Q92753 1/20 0.36
RAB9A P51151 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5786488 0.82 RAB9A (0.43) L3MBTL1RAB9ACYP3A4
SCHEMBL29357073 0.77 RPS6KB1 (0.45) RPS6KB1L3MBTL1PLA2G1BATG4BCYP11B1
SCHEMBL29355505 0.75 RPS6KB1 (0.43) RPS6KB1L3MBTL1PLA2G1BATG4BCYP11B1
SCHEMBL29358907 0.74 RPS6KB1 (0.42) RPS6KB1CYP11B1CYP11B2AKT1GPR52
SCHEMBL29358387 0.70 HPGDS (0.41) RPS6KB1CYP11B1CYP11B2BRS3AKT1
SCHEMBL29355501 0.70 GPR52 (0.41) RPS6KB1L3MBTL1PLA2G1BATG4BCYP11B1
SCHEMBL29355361 0.69 GPR52 (0.40) CYP11B1CYP11B2BRS3GPR52CYP3A4
SCHEMBL29356932 0.69 PLA2G1B (0.41) RPS6KB1L3MBTL1PLA2G1BATG4BCYP11B1
SCHEMBL27964788 0.68 RORB (0.68) RPS6KB1RORBRAB9APDE4D
SCHEMBL29359158 0.68 HPGDS (0.43) RPS6KB1CYP11B1CYP11B2BRS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941908-A1 COMPOUNDS AND USES THEREOF Yumanity Therapeutics, Inc. (US) 2022-01-26 EP disclosed